Abstract
• CO-RADS improves the risk classification by 65.8% in patients affected by COVID-19. • CO-RADS combined with RT-PCR presents an AUC of 0.98 for patients with COVID-19. • CO-RADS improves the risk classification by 82.1% in patients not affected by COVID-19.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have